Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Phase III Clinical Trials Pooled Analysis Results. J of Skin 2017, 1 (3.1), s102. https://doi.org/10.25251/skin.1.supp.101.